Pemphigus Unknown Status Phase Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Unknown StatusNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01338103Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via CylexTreatment